Chromocell Therapeutics Corp
AMEX:CHRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
UAngel Corp
KRX:072130
|
KR |
|
V
|
Vinafreight JSC
VN:VNF
|
VN |
|
Vistar Holdings Ltd
HKEX:8535
|
HK |
|
Aukett Swanke Group PLC
LSE:AUK
|
UK |
|
A
|
Avaco Co Ltd
KOSDAQ:083930
|
KR |
|
CB Financial Services Inc
NASDAQ:CBFV
|
US |
|
Frencken Group Ltd
SGX:E28
|
MY |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
CA |
|
S
|
Stolt-Nielsen Ltd
LSE:0OHK
|
UK |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
|
Assystem SA
PAR:ASY
|
FR |
|
Weimob Inc
HKEX:2013
|
CN |
|
Stantec Inc
TSX:STN
|
CA |
|
M
|
MasterBrand Inc
NYSE:MBC
|
US |
|
TradeGo FinTech Ltd
HKEX:8017
|
HK |
|
Capital Bancorp Inc
NASDAQ:CBNK
|
US |
|
C
|
China Oil and Gas Group Ltd
HKEX:603
|
HK |
|
C
|
COFCO Sugar Holding Co Ltd
SSE:600737
|
CN |
|
I
|
InFocus Group Holdings Ltd
ASX:IFG
|
AU |
|
Movella Holdings Inc
OTC:MVLA
|
US |
|
Lineage Inc
NASDAQ:LINE
|
US |
Bankruptcy Probability
Chromocell Therapeutics Corp's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chromocell Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
3.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chromocell Therapeutics Corp's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chromocell Therapeutics Corp has total debt of 2.5m USD. This includes both short-term (2.5m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
